EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Sarcopenia and sarcopenic obesity among community-dwelling Peruvian adults: A cross-sectional study

Oscar Flores-Flores iD, Alejandro Zevallos-Morales iD, Suzanne L Pollard, William Checkley, Trishul Siddharthan, John R Hurst, Antonio Bernabé-Ortiz, Fernando M Runzer-Colmenares, Miles D Witham, Jose F Parodi iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0300224 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Oscar Flores-Flores und 9 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de San Martin de Porres, Facultad de Medicina Humana, Centro de Investigación del Envejecimiento (CIEN), Lima, Peru. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, FIC NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sarcopenia and sarcopenic obesity (SO) have emerged as significant contributors to negative health outcomes in the past decade. We aimed to estimate the prevalence of probable sarcopenia, sarcopenia, and SO in a community-dwelling population of 1151 adults aged ≥55 years in Lima, Peru.

Methods

This cross-sectional study was conducted between 2018 and 2020. Sarcopenia was defined as the presence of low muscle strength (LMS) and low muscle mass (LMM) according to European (EWGSOP2), US (FNIH) and Asian (AWGS2) guidelines. We measured muscle strength by maximum handgrip strength and muscle mass using bioelectrical impedance analyzer. SO was defined as a body mass index ≥ 30 kg/m 2 and sarcopenia.

Results

The study participants had a mean age of 66.2 years (SD 7.1), age range between 60 to 92 years old, of which 621 (53.9%) were men. Among the sample, 41.7% were classified as obese (BMI ≥30.0 kg/m²). The prevalence of probable sarcopenia was estimated to be 22.7% (95%CI: 20.3–25.1) using the EWGSOP2 criteria and 27.8% (95%CI: 25.2–30.4) using the AWGS2 criteria. Sarcopenia prevalence, assessed using skeletal muscle index (SMI), was 5.7% (95%CI: 4.4–7.1) according to EWGSOP2 and 8.3% (95%CI: 6.7–9.9) using AWGS2 criteria. The prevalence of sarcopenia based on the FNIH criteria was 18.1% (95%CI: 15.8–20.3). The prevalence of SO, considering different sarcopenia definitions, ranged from 0.8% (95%CI: 0.3–1.3) to 5.0% (95%CI: 3.8–6.3).

Conclusion

Our findings reveal substantial variation in the prevalence of sarcopenia and SO, underscoring the necessity for context-specific cut-off values. Although the prevalence of SO was relatively low, this result may be underestimated. Furthermore, the consistently high proportion of probable sarcopenia and sarcopenia point to a substantial public health burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaAdultMaleHumansAgedMiddle AgedAged, 80 and overFemaleIndependent LivingCross-Sectional StudiesPeruHand StrengthObesityPrevalence

Autor:innen und Institutionen

  • Universidad de San Martin de Porres, Facultad de Medicina Humana, Centro de Investigación del Envejecimiento (CIEN), Lima, Peru.
  • Asociación Benéfica PRISMA, Lima, Peru.
  • Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Center for Global Non-Communicable Disease Research and Training, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Division of Pulmonary and Critical Care, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • UCL Respiratory, University College London, London, United Kingdom.

ORCID-Profile: Oscar Flores-Flores, Alejandro Zevallos-Morales, Jose F Parodi

Förderung

  • NHLBI NIH HHS
  • FIC NIH HHS
  • NIEHS NIH HHS
  • Medical Research Council
  • Fogarty International Center
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Flores-Flores, O., Zevallos-Morales, A., Pollard, S. L., Checkley, W., Siddharthan, T., Hurst, J. R., Bernabé-Ortiz, A., Runzer-Colmenares, F. M., Witham, M. D., & Parodi, J. F. (2024). Sarcopenia and sarcopenic obesity among community-dwelling Peruvian adults: A cross-sectional study. PLOS ONE. https://doi.org/10.1371/journal.pone.0300224

Vancouver

Flores-Flores O, Zevallos-Morales A, Pollard SL, Checkley W, Siddharthan T, Hurst JR, et al. Sarcopenia and sarcopenic obesity among community-dwelling Peruvian adults: A cross-sectional study. PLOS ONE. 2024. doi:10.1371/journal.pone.0300224

BibTeX
@article{FloresFlores2024,
  author = {Flores-Flores, Oscar and Zevallos-Morales, Alejandro and Pollard, Suzanne L and Checkley, William and Siddharthan, Trishul and Hurst, John R and Bernabé-Ortiz, Antonio and Runzer-Colmenares, Fernando M and Witham, Miles D and Parodi, Jose F},
  title = {Sarcopenia and sarcopenic obesity among community-dwelling Peruvian adults: A cross-sectional study},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0300224}
}
Kostenlos starten →